Suchergebnisse - "Fang, Weijia"

PubPharm (157)

1

Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Liu, C. | Xie, J. | Lin, B. | +16

2

A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma : A 16-year prospective multicentric study

enthalten in: Cancer letters | 2024

von Liu, C. | Cheng, X. | Han, K. | +13

3

S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function

enthalten in: Journal of experimental & clinical cancer research : CR | 2024

von Tu, X. | Chen, L. | Zheng, Y. | +14

4

$ S100A9^{+} %$ CD14^{+} $ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function

enthalten in: Journal of experimental & clinical cancer research | 2024

von Tu, X. | Chen, L. | Zheng, Y. | +14

5

Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells

enthalten in: Nature materials | 2024

von Shi, J. | Wu, W. | Chen, D. | +19

6

A multiomics analysis-assisted deep learning model identifies a macrophage-oriented module as a potential therapeutic target in colorectal cancer

enthalten in: Cell reports. Medicine | 2024

von Bao, X. | Li, Q. | Chen, D. | +23

7

A case of dMMR/MSI-H/TMB-H colon cancer with brain metastasis treated with PD-1 monoclonal antibody

enthalten in: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences | 2024

von Xiang, T. | Zhang, H. | Fang, W. | +1

8

Nano-enhanced immunotherapy : Targeting the immunosuppressive tumor microenvironment

enthalten in: Biomaterials | 2024

von Jin, Y. | Huang, Y. | Ren, H. | +12

9

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Llovet, J. | Kudo, M. | Merle, P. | +123

ErratumIn: Lancet Oncol. 2024 Apr;25(4):e137. - PMID 38547896

10

Development of a whole-slide-level segmentation-based dMMR/pMMR deep learning detector for colorectal cancer

enthalten in: iScience | 2023

von Tong, Z. | Wang, Y. | Bao, X. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]